Business
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Bausch Health Announces 2025 Annual Meeting of Shareholder ResultsLAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders (\"Annual Meeting\") held on May 13, 2025. The detailed results of the vote for the election of directors are set out below:Name For Withheld Broker Non-VotesThomas J. Appio 208,400,572 5,943,436 56,339,806Christian A. Garcia 207,181,762 7,162,246 56,339,806Brett M. Icahn 199,179,508 15,164,500 56,339,806Sarah B. Kavanagh 208,164,244 6,179,764 56,339,806Frank D. Lee 207,489,891 6,854,117 56,339,806Steven D. Miller 206,805,726 7,538,282 56,339,806Richard C. Mulligan, Ph.D. 202,866,703 11,477,305 56,339,806John A. Paulson 205,916,286 8,427,722 56,339,806Robert N. Power 202,283,418 12,060,590 56,339,806Amy B. Wechsler, M.D. 207,392,798 6,951,210 56,339,806At the Annual Meeting, shareholders also approved the non-binding advisory vote on the compensation of the Company's named executive officers, approved the Bausch Health Companies Inc. 2025 Employee Stock Purchase Plan (\"ESPP\"), and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2026 annual meeting of shareholders.For the purposes of Toronto Stock Exchange (\"TSX\") approval with respect to the ESPP, the Company relied on the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible inter-listed issuers on a recognized exchange, such as the NYSE.The final vote tabulation on all matters voted on at the meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's SEDAR profile and on the Company's website at www.bauschhealth.com.About Bausch HealthBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling...